CD8A and melanoma: The authors report that BRAF/VEGFA targeting reverses immune cell exclusion by increasing the infiltration of CD8 T cells and M1–macrophages, allowing remodeling of the tumor microenvironment and sensitizing melanoma cells to immune checkpoint blockade.